Roivant Sciences Ltd (ROIV)
11.41
-0.09
(-0.78%)
USD |
NASDAQ |
May 16, 16:00
11.41
0.00 (0.00%)
After-Hours: 20:00
Roivant Sciences Price: 11.41 for May 16, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 16, 2024 | 11.48 | 11.48 | 11.34 | 11.41 | 3.055M |
May 15, 2024 | 11.53 | 11.65 | 11.46 | 11.50 | 2.900M |
May 14, 2024 | 11.27 | 11.35 | 11.14 | 11.33 | 2.639M |
May 13, 2024 | 11.11 | 11.25 | 11.10 | 11.18 | 2.273M |
May 10, 2024 | 11.38 | 11.48 | 11.12 | 11.13 | 2.570M |
May 09, 2024 | 11.23 | 11.28 | 11.06 | 11.25 | 3.959M |
May 08, 2024 | 11.28 | 11.31 | 10.98 | 11.21 | 5.093M |
May 07, 2024 | 11.63 | 11.63 | 11.37 | 11.38 | 3.754M |
May 06, 2024 | 11.46 | 11.64 | 11.37 | 11.60 | 3.445M |
May 03, 2024 | 11.48 | 11.50 | 11.28 | 11.39 | 3.693M |
May 02, 2024 | 11.34 | 11.35 | 11.14 | 11.24 | 3.331M |
May 01, 2024 | 11.00 | 11.34 | 10.90 | 11.21 | 5.558M |
Apr 30, 2024 | 11.03 | 11.14 | 10.89 | 10.90 | 4.553M |
Apr 29, 2024 | 11.00 | 11.28 | 10.99 | 11.13 | 5.225M |
Apr 26, 2024 | 10.95 | 11.11 | 10.88 | 11.03 | 3.110M |
Apr 25, 2024 | 10.78 | 10.91 | 10.51 | 10.88 | 3.720M |
Apr 24, 2024 | 10.93 | 11.05 | 10.78 | 10.90 | 2.837M |
Apr 23, 2024 | 10.65 | 11.05 | 10.60 | 10.94 | 4.979M |
Apr 22, 2024 | 10.52 | 10.82 | 10.36 | 10.60 | 5.324M |
Apr 19, 2024 | 10.30 | 10.48 | 10.26 | 10.46 | 4.664M |
Apr 18, 2024 | 10.40 | 10.50 | 10.32 | 10.36 | 3.420M |
Apr 17, 2024 | 10.76 | 10.80 | 10.42 | 10.44 | 4.076M |
Apr 16, 2024 | 10.77 | 10.92 | 10.64 | 10.71 | 4.732M |
Apr 15, 2024 | 10.98 | 11.04 | 10.81 | 10.84 | 5.009M |
Apr 12, 2024 | 11.10 | 11.13 | 10.83 | 10.94 | 6.347M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.81
Minimum
May 12 2022
13.52
Maximum
Dec 20 2021
8.393
Average
9.51
Median
Jan 04 2022
Price Benchmarks
Adaptimmune Therapeutics PLC | 1.20 |
Biodexa Pharmaceuticals Plc | 1.24 |
Verona Pharma PLC | 13.36 |
NuCana PLC | 3.67 |
Autolus Therapeutics PLC | 4.07 |
Price Related Metrics
PE Ratio | 2.194 |
PS Ratio | 72.12 |
Price to Book Value | 1.510 |
Earnings Yield | 45.57% |
Market Cap | 9.195B |